Acute Porphyria Drugs

C03CC01 - Etacrynic Acid

Probably not porphyrinogenic
PNP

Mono.Rationale
CAVE: under revision. Water-soluble substance. Non-CYP metabolism. No data pointing to CYP-interaction.
Mono.ChemicalDescription
Etacrynic acid is not a sulfonamide congener unlike many other diuretics.
Mono.TherapeuticCharacteristics
Loop-diuretic, short acting.
Mono.MetabolismAndPharmacokinetics
Conjugation occurs in the liver with compounds containing sulfhydryl groups, such as cysteine and N-acetylcysteine. This seems to be the major metabolic pathway. Etacrynic acid is excreted both in the bile and the urine, partly unchanged and partly in the form of metabolites. An in vitro study with rat liver microsomes indicates oxidative metabolism via the CYP450-system. It is not known to which extent such metabolism occurs in man.
Mono.PreclinicalData
None. No data pointing to CYP-induction.
Mono.PersonalCommunication
None
Mono.PublishedExperience
NOne
Mono.SimilarDrugs
Mono.ExploreAlternatives C03C / C03CC or Mono.GoBack.
Mono.References
# Citation details PubMed ID
1. Rat liver microsomal lipid peroxidation produced during the oxidative metabolism of ethacrynic acid.
Yamamoto K, Masubuchi Y, et al. Pharmacol Toxicol. 2001 Apr; 88(4):176-80.
11322174
Mono.Tradenames

Uregyt Reomax Edecrin · Edecrina · Ethacrynic Acid · Reomax Edecril Edecrin · Ethacrynate Edecrin · Ethacrynic acid · Hydromedin · Reomax Acide etacrynique Acido etacrinico Etacrynic acid
In cooperation with Ipnet
© Napos 2026
An unhandled error has occurred. Reload 🗙